Research and Markets: RNA Interference (RNAi) - Global Strategic Business Report

DUBLIN -- (BUSINESS WIRE) -- Research and Markets (http://www.researchandmarkets.com/research/h73vh5/rna_interference) has announced the addition of the "RNA Interference (RNAi) - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for RNA Interference (RNAi) in US$ Million by the following Application Areas: Drug Discovery and Target Validation, Reagents, and siRNA Synthesis. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Key Topics Covered

I. Introduction, Methodology & Product Definitions

II. Executive Summary

1. Industry Outlook

2. Industry Overview

3. Market Outlook

4. Product Overview

5. Applications of RNA Interference

6. Regulatory Approvals

7. Technological Innovations

8. Recent Industry Activity

9. Strategic Corporate Developments - A Historic Perspective Builder

10. Focus On Select Global Players

11. Global Market Perspective

III. Market

1. The United States

2. Canada

3. Japan

4. Europe

5. Asia-Pacific

6. Rest Of World

IV. Competitive Landscape

Companies Mentioned

The report profiles 135 companies including many key and niche players such as

- Alnylam Pharmaceuticals

- Benitec Limited

- Bioneer Corp.

- Calando Pharmaceuticals

- Cenix BioScience GmbH

- Devgen NV

- Dharmacon

- Dicerna Pharmaceuticals

- Exiqon A/S

- Genesis Research & Development Corporation Limited

- Halo-Bio RNAi Therapeutics

- Marina Biotech

- OPKO Health

- Polyplus-transfection

- Quark Pharmaceuticals

- Galena Biopharma

- Sigma-Aldrich Co.

- Silence Therapeutics

- Tekmira Pharmaceuticals Corp.

For more information visit http://www.researchandmarkets.com/research/h73vh5/rna_interference